International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 6 minute read Pharma Industry News Neurogene (NASDAQ: NGNE) advances Rett syndrome gene therapy with Embolden trial launch and positive pediatric data Neurogene reports progress on NGN-401 Rett syndrome gene therapy with pivotal trial launch and strong pediatric data. See what’s ahead in 2026. bySrinathNovember 14, 2025